Diabetes Typ 1 um Jahre hinauszögern: Neues Medikament für Kinder im Frühstadium zugelassen Das Medikamnet mit dem Wirkstoff Teplizumab ist für Kinder mit Typ-1-Diabetes im Frühstadium neu zugelassen. Es soll die Krankheit hinauszögern.

#Teplizumab
#Diabetes
#MECFS

Neues Medikament verzögert Ausbruch von Diabetes Typ 1 www.zdfheute.de/ratgeber/ges...

Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes - Diabetologia Aims/hypothesis This is the first real-world prospective observational study of teplizumab use following approval by the United States Food and Drug Administration in individuals with stage 2 type 1 d...

Research physicians at Barbara Davis Center for Diabetes studied the effects #teplizumab has on treating stage 2 #T1D.

Teplizumab treatment for stage 2 #type1diabetes: a real-world evaluation of metabolic and immunological outcomes - Diabetologia link.springer.com/article/10.1...

#T1Dresearch

Illustration depicting the treatment and research findings on Teplizumab therapy in two individuals with Stage 2 Type 1 Diabetes associated with Autoimmune Polyendocrine Syndrome Type 1 (APS-1). The image shows molecular interactions, treatment action, and improved glucose measures, alongside effects on immune cells and thymus size. Notable elements include AIRE mutation, specific genes — GAD, IA-2, ZNT8A, and changes in CD4+ and CD8+ cell counts in the peripheral blood.

Two individuals with distinct, APS-1 associated mutations and stage 2 type 1 diabetes showed improved BG & reverted to earlier stage T1D after teplizumab. More research needed! #T1D #APS1 #Teplizumab

Read here ➡️ doi.org/10.2337/dc25-1444

Prever diabetes tipo 1 al nacer: la pista está en el cordón Proteínas en sangre del cordón y modelos predictivos apuntan a detectar riesgo de diabetes tipo 1 desde el nacimiento y durante el embarazo. La diabetes tipo 1, esa enfermedad que suele irrumpir de go...

Prever diabetes tipo 1 al nacer: la pista está en el cordón #DiabetesTipo1 #Salud #Ciencia #Investigacion #Medicina #Pediatria #Embarazo #CordónUmbilical #Inmunologia #Endocrino #Teplizumab #Teizeild #29deenero #felizjueves donporque.com/prever-diabe...

Teplizumab: Erstes Medikament zur Verzögerung von Typ-1-Diabetes zugelassen Die EU-Kommission hat Sanofi die Zulassung für den Antikörper Teplizumab (Teizeild®) erteilt. Er soll die Entwicklung der Autoimmunerkrankung...

Die EU-Kommission hat Sanofi die Zulassung für den Antikörper #Teplizumab (Teizeild®) erteilt. Er soll die Entwicklung der Autoimmunerkrankung #Typ-1-Diabetes verzögern. Der Einsatz ist jedoch auf ein bestimmtes Stadium begrenzt.

¿Cómo actúa Teizeild y cuánto retrasa la diabetes tipo 1? La EMA respalda Teizeild (teplizumab), terapia que retrasa la diabetes tipo 1 hasta 50 meses. Qué cambia en Europa y el acceso real en la UE. La Agencia Europea de Medicamentos (EMA) ha emitido un dic...

¿Cómo actúa Teizeild y cuánto retrasa la diabetes tipo 1? #Teizeild #Teplizumab #DiabetesTipo1 #EMA #Salud #UE #España #Endocrinología #Inmunoterapia #DíaMundialDeLaDiabetes #14denoviembre #felizviernes #CHMP #FDA #MHRA donporque.com/como-actua-t...

Endocrinology Weekly Update – August 19th 2025 🧬 Endocrinology Update: Gamified Insulin Pump, AI in Thyroid Cancer, Teplizumab Approval and More Stay on top of the latest […] The post Endocrinology Weekly Update – August 19th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Endocrinology Weekly Update – August 19th 2025 #News #Teplizumab #AIinhealthcare #endocrinology #glp1 Comment below!

Teplizumab becomes UK's ‘first-ever’ approved immunotherapy for type 1 diabetes An immunotherapy has been approved by the UK medicines regulator to delay the development of type 1 diabetes.

Teplizumab becomes UK's ‘first-ever’ approved immunotherapy for type 1 diabetes

buff.ly/Yl3mgWy

#UKpharmacy #diabetes #type1diabetes #immunotherapy #teplizumab

Endocrinology Weekly Update – August 19th 2025 🧬 Endocrinology Update: Gamified Insulin Pump, AI in Thyroid Cancer, Teplizumab Approval and More Stay on top of the latest […] The post Endocrinology Weekly Update – August 19th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Endocrinology Weekly Update – August 19th 2025 #News #Teplizumab #AIinhealthcare #endocrinology #glp1 Comment below!

Endocrinology Weekly Update – August 19th 2025 🧬 Endocrinology Update: Gamified Insulin Pump, AI in Thyroid Cancer, Teplizumab Approval and More Stay on top of the latest […] The post Endocrinology Weekly Update – August 19th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Endocrinology Weekly Update – August 19th 2025 #News #Teplizumab #AIinhealthcare #endocrinology #glp1 Comment below!

The idea of giving #immunotherapy to young, normoglycaemic people seemed outrageous. Then, a paper came along that Prof. Colin Dayan ( @cardiffuni.bsky.social ) presents in the latest #Gamechangers episode.

📺 Watch here: easd-elearning.eu/episode/338/...

#Teplizumab #Autoantibodies #Type1Diabetes

#Teplizumab, retour sur expérience

Eligibilité :
▪️ >8 ans
▪️ >=2AA
▪️ Stade 2
▪️ HGP
-A Besancon

#congresSFD #SFD2025 #dedoc°@dedocORG #NothingAboutUsWithoutUs #PayItForward

🧵 #Teplizumab, retour sur expérience

🇺🇸 Médiane d’apparition du #DT1 Stade 3 à 6 ans:
▪️ 52 mois Teplizumab
▪️ 27 mois placebo

🇫🇷 Accès compassionnel
-A Besancon

#congresSFD #SFD2025 #dedoc°@dedocORG #NothingAboutUsWithoutUs #PayItForward

New study analysing #TrialNet data to look at #T1D disease heterogeneity & response to #teplizumab #Diabetes #Endocrinology #DiabetesResearch